Order Article Reprints

Arnon J, Tabi M, Rottenberg Y, Zick A, Blumenfeld P, Hamburger T, Pikarsky E, Avraham E, Levine L, Popovtzer A, et al. Clinical Characteristics, Response to Platinum-Based Chemotherapy and Poly (Adenosine Phosphate-Ribose) Polymerase Inhibitors in Advanced Lung Cancer Patients Harboring BRCA Mutations. Cancers. 2023; 15(19):4733. https://doi.org/10.3390/cancers15194733

Arnon, Johnathan, Michael Tabi, Yakir Rottenberg, Aviad Zick, Philip Blumenfeld, Tamar Hamburger, Eli Pikarsky, Eti Avraham, Leeby Levine, Aron Popovtzer, and et al. 2023. "Clinical Characteristics, Response to Platinum-Based Chemotherapy and Poly (Adenosine Phosphate-Ribose) Polymerase Inhibitors in Advanced Lung Cancer Patients Harboring BRCA Mutations" Cancers 15, no. 19: 4733. https://doi.org/10.3390/cancers15194733

Arnon, J., Tabi, M., Rottenberg, Y., Zick, A., Blumenfeld, P., Hamburger, T., Pikarsky, E., Avraham, E., Levine, L., Popovtzer, A., Yablonski-Peretz, T., Kadouri, L., & Nechushtan, H. (2023). Clinical Characteristics, Response to Platinum-Based Chemotherapy and Poly (Adenosine Phosphate-Ribose) Polymerase Inhibitors in Advanced Lung Cancer Patients Harboring BRCA Mutations. Cancers, 15(19), 4733. https://doi.org/10.3390/cancers15194733